ArticleTranslational pediatrics2026
Infantile cholestasis caused by pituitary stalk interruption syndrome: a case report and review of the literature.
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pituitary stalk interruption syndrome (PSIS) is a clinical syndrome caused by the absence or thinning of the pituitary stalk. This syndrome mainly impairs the transport of hormones from the hypothalamus to the posterior pituitary gland and affects the action of relevant hormones on the anterior pituitary gland, thereby leading to common clinical manifestations such as diabetes insipidus, growth retardation, gonadal dysplasia, hypothyroidism, and adrenocortical hypofunction. In PSIS, cases presenting with infantile cholestasis as the initial and prominent manifestation are relatively rare and prone to misdiagnosis. Case Description: A boy aged 2 months was admitted for cholestatic liver disease, presenting with poor response to routine choleretic therapy, non-elevated gamma-glutamyl transferase (GGT) level, hypothyroidism and recurrent hypoglycemia. Difficulties were encountered in identifying the etiology of common infantile cholestatic liver disease with non-elevated GGT. Subsequently, cranial magnetic resonance imaging (MRI) and genetic testing were completed focusing on the symptoms related to the endocrine axis, leading to a definitive diagnosis of PSIS. The infant achieved stable and favorable therapeutic outcomes after receiving combined treatment by endocrinologists and gastroenterologists during follow-up. Conclusions: The prominent feature of this case was infantile cholestatic liver disease accompanied by hypoglycemia and hypothyroidism. For infants, hypoglycemia and hypothyroidism should not be overlooked, and close monitoring is required. As pediatric gastroenterologists, when routine treatment fails for infantile cholestatic liver disease, we need to consider the possibility of cholestasis caused by hypothalamic-pituitary axis abnormality, and conduct relevant imaging examinations, hormone level tests and genetic tests when necessary. At this point, the joint diagnosis and treatment by gastroenterologists and endocrinologists is particularly important.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.